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Abstract 
Serious brain disorders, such as the Alzheimer's Disease (AD), are associated with a marked 
drop in the levels of important neurotransmitters, such as acetylcholine (ACh). Real time 
monitoring of such biomarkers can therefore play a critical role in enhancing AD therapies by 
allowing timely diagnosis, verifications of treatment effectiveness, and developments of new 
medicines. In this study, we present the first acetylcholine/oxygen hybrid enzymatic fuel cell for 
the self-powered on site detection of ACh in plasma, which is based on the combination of an 
enzymatic anode with a Pt cathode. Firstly, an effective acetylcholinesterase immobilized 
electrode was developed and its electrochemical performance evaluated. Highly porous gold was 
used as the electrode material, and the enzyme was immobilized via a one step rapid and simple 
procedure that does not require the use of harsh chemicals or any electrode/enzyme pre-
treatments. The resulting enzymatic electrode was subsequently used as the anode of a miniature 
flow-through membrane-less fuel cell and showed excellent response to varying concentrations 
of ACh. The peak power generated by the fuel cell was 4 nW at a voltage of 260 mV and with a 
current density of 9 μA cm-2. The limit of detection of the fuel cell sensor was 10 μM, with an 
average response time as short as 3 minutes. These exciting results open new horizons for point-
of-care Alzheimer diagnosis and provide an attractive potential alternative to established 
methods that require laborious and time-consuming sample treatments and expensive 
instruments. 
 
Keywords: 
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1. INTRODUCTION 
Dementia describes a set of symptoms that include memory loss and difficulties with thinking, 
problem-solving and language. Worldwide, over 35 million people are currently diagnosed with 
dementia. This number that is estimated to double every 20 years in aging populations, thus 
reaching a value of 65.7 million in 2030, and of 115.4 million in 2050 (Prince et al. 2015). The 
most common cause of senile dementia is the Alzheimer’s disease (AD), with currently over 17 
million cases worldwide (Mayeux and Schupf 2011). AD is characterized by the progressive loss 
of cognitive function and personality changes. Early detection of AD, as well as the capability to 
distinguish it from other forms of dementia, is key to plan timely caring actions and help families 
intervene before the disease becomes too serious. Yet, so far, there are no definitive diagnostic 
tests that allow accurate and effective early detection of this condition. The diagnosis of AD 
occurs typically via extensive clinical examinations based on specific clinical diagnostic criteria 
that have been established in 1984 by the National Institute of Neurological and Communicative 
Disorders and Stroke (NINCDS) and the Alzheimer’s Disease and Related Disorders Association 
(ADRDA), known as the NINCDS-ADRDA Alzheimer’s criteria (McKhann et al. 1984). 
The identification of relevant biomolecules that could act as AD biomarkers, and therefore allow 
rapid and effective diagnosis of this disease, is of particular relevance. Recent studies have 
suggested that systemic signs caused by concentration changes of specific biomolecules, which 
include mostly the Amyloid-β and Tau proteins present in cerebrospinal fluid (CSF) and plasma, 
can be associated with the progression of AD (Kanai et al. 1998). A particularly promising route 
to diagnose AD is, however, represented by the possibility to monitor the levels of 
neurotransmitters, such as acetylcholine (ACh), in cerebrospinal fluid. ACh is one of the first 
identified neurotransmitters and is found in the peripheral and central nerve system of the brain 
(Cannon et al. 2004; Hou et al. 2012). The role of ACh is to transmit messages from motor 
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nerves to muscles, especially to the heart, bladder and stomach, and ACh is involved in several 
functions, including cognition, memory and movement (Hasselmo and Sarter 2010; Van der Zee 
and Luiten 1999). The dysfunction in ACh regulation in the brain causes neuropsychiatric 
disorders such as Alzheimer’s disease, Parkinson’s disease, progressive dementia, Myasthenia 
Gravis and schizophrenia (Davis and Berger 1979; Tandon 1999). Considering the importance of 
this biomolecule, there is high interest in developing methods for its in vivo quantification 
(Garris and A 2010). Real-time monitoring of extra-cellular concentration changes of ACh 
would in fact allow understanding the function of the nervous system and the association to AD, 
examining the degeneration of cholinergic neural systems in AD, and evaluating pharmaceuticals 
that affect cholinergic activity at the single cell level (Mitchell 2004; Nguyen et al. 2010). 
Nonetheless, current methods to determine ACh levels in body fluids, such as ELISA (Hinman et 
al. 1986; Kawanami et al. 1984) and microdialysis sampling combined to offline analysis by 
liquid chromatography with mass spectroscopy detection (Nirogi et al. 2010; Song et al. 2012; 
Uutela et al. 2005), are laborious, expensive, slow and not suitable for in situ monitoring. 
Electrochemical sensors are capable of fast in situ detection sensors and, therefore, offer a 
powerful avenue for real time diagnostics that overcomes the drawback of traditional analytical 
methods (Wilson and Gifford 2005). In particular, the detection of ACh and its metabolite 
choline (Ch) has been successfully demonstrated with enzyme-based amperometric sensors. 
Depending on the specific target, the sensors use either acetylcholine esterase (AChE) or choline 
oxidase (ChOx), as well as both enzymes together (Garguilo and Michael 1995; Hou et al. 2012; 
Mitchell 2004; Wise et al. 2002). AChE-based sensors have been also suggested for the detection 
of toxic organophosphorous pesticides that, by inhibiting the activity of this enzyme, lead to 
toxic levels of acethylcholine in the cells, with severe threat to human health (Cai et al. 2014; 
Kaur and Srivastava 2015).  
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In this work, we propose the first hybrid enzymatic fuel cell (EFC)-based sensor for the real time 
and in situ detection of ACh. EFCs are a particular type of fuel cells that use enzymes to catalyse 
the direct generation of electricity from physiological fluids under body temperature and 
pressure (Barton et al. 2004) (du Toit and Di Lorenzo 2015). As such, EFC provide an attractive 
possibility for implantable and wearable diagnostic devices (Leech et al. 2012) (du Toit et al. 
2016). Preliminary proof-of-concept studies in this direction are highly encouraging. EFCs have 
been successfully implanted in living organisms, thus showing electricity generation from 
physiological fluids, such as blood and plasma (Castorena-Gonzalez et al. 2013; Halámková et 
al. 2012; MacVittie et al. 2013). Some successful examples of wearable EFCs have also been 
reported, such as the tattoo EFC that generates electricity from lactate in sweat (Jia et al. 2013) 
and the contact lens that uses the glucose in tears as fuel (Reid et al. 2015). Considering that 
within a specific range the power generated is proportional to the amount of substrate (the 
analyte) in the input solution, the most intuitive use of EFCs is as self-powered amperometric 
sensors for that substrate. By varying the nature of the enzyme(s) employed, several biomarkers 
of interest could be detected. The majority of the EFCs reported so far, uses the enzymes glucose 
oxidase and glucose dehydrogenase and focus on the detection of glucose (Ivanov et al. 2010). 
An EFC embedded into microfluidic follow-channels paper was reported for the detection of the 
carcinoembryonic antigen (Li et al. 2015). Successful examples of EFC applications as sensor 
for the detection of lactate (Katz et al. 2001), cyanide (Deng et al. 2010), mercury ion (Wen et al. 
2011) and cholesterol (Sekretaryova et al. 2014) have also been reported. 
The innovative enzymatic fuel cell reported in the present work utilizes at the anode the 
enzyme acetylcholinesterase (AChE), which is immobilized onto a nanostructured electrode 
made of a highly porous gold (hPG) coated onto a Pt surface. The use of nanostructured 
electrode materials is key to improve the enzyme loading and enhance the electrochemical 
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performance of EFCs (Ivanov et al. 2010). hPG in particular has proven to be an excellent 
candidate for EFCs, given its large specific surface area, biocompatibility and non-toxicity (du 
Toit and Di Lorenzo 2014b). In this study, we used a rapid and simple one-step electrochemical 
process to immobilise AChE onto hPG that does not require complex or laborious electrode 
and/or enzyme pre-treatments. The first part of this study focus on investigating the 
electrochemical performance of the resulting electrode. Subsequently, the enzymatic electrode is 
tested as the anode of a flow-through membrane-less fuel cell and the current and power output 
is recorded for a series of ACh concentrations, thus proving its use as online sensor. 
 
2. EXPERIMENTAL SECTION 
2.1 Materials 
All the chemicals were of analytical reagent grade and were used without further purification. 
Acetylcholinesterase from Electrophorus electricus, 500 U, was purchased from Sigma-Aldrich. 
The Saturated Calomel Electrode (SCE), used as the reference electrode, was purchased from 
IJCambria Ltd. Platinum wire (diameter: 0.5 mm) was purchased from Cookson Precious Metals 
Ltd. Polydimethylsiloxane (PDMS, Dow Corning Sylgard 184) was purchased from Ellsworth 
Adhesives. 
All aqueous solutions used were prepared using reverse osmosis purified water. The phosphate 
buffered saline (PBS) solution was prepared on a weekly basis and consisted of 137 mM NaCl, 
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4. The pH of the resulting solution was adjusted to 
a value of 7.4 with the drop-wise addition of HCl or NaOH. Glycine buffer was prepared by 
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mixing 0.01 M of Glycine with 0.1 M of NaCl and by adjusting the pH to 7.4 by drop-wise 
addition of NaOH and HCl. 
All potentiostatically-controlled electrochemical processes were performed using the Autolab 
PGSTAT128 N (Metrohm, UK) potentiostat. The moulds for the PDMS structures were 3D 
printed in polylactic acid using a Makerbot Replicator. 
2.2 Preparation of the electrodes 
The electrodes were prepared by electrodepositing a film of highly porous gold (hPG) onto Pt 
wires via a hydrogen bubbling template, as previously described (du Toit and Di Lorenzo 
2014a). Briefly, the platinum wires were immersed in an electrolyte consisting of 0.1 M HAuCl4 
and 1 M NH4Cl and gold was deposited by gradually stepping down the working potential as 
follows: -0.7 V (vs. SCE) for 5 s; -1.5 V (vs. SCE) for 5 s; -2.5 V (vs. SCE) for 5 s and-4.0 V 
(vs. SCE) for 10 s. This process was performed in a three electrode set-up, with platinum as the 
counter electrode and SCE as the reference electrode. This set-up was also used for the 
immobilization of AChE onto the hPG/Pt electrode. The electrodes were immerged in a PBS 
buffer (pH 7.4) containing 6.25 U mL-1 of enzyme, and a potential of 0.6 V vs SCE was applied 
for one hour, according to the immobilization protocol previously established by our group (du 
Toit et al. 2016).  
 
The electrochemical response of both AChE/hPG/Pt and hPG/Pt electrodes to ACh, within the 
range of 2- 2400 g mL-1, was evaluated by both chronoamperometry (CA) and Square Wave 
Voltammetry (SWV) in the conventional three-electrode set-up (SCE as the reference electrode, 
Pt as the counter electrode). During the test, ACh was drop-wise added to the buffer solution 
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until the target concentration. The solution was then stirred for 30 seconds before the 
measurement. The response to ACh was evaluated in terms of current variation, Δi=ic-i0, where, 
ic is the observed current at the set concentration and i0 is the baseline current in the absence of 
substrate. 
The sensitivity towards ACh was obtained from the slope, b (µA mM-1), of the calibration 
curve and was referred to the total surface area, A (cm2), of the electrode as: 
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑏
𝐴
 
The electrodes performance was also tested by cyclic voltammetry at a scan rate of 50 mV s-1 
in the presence and absence of ACh. The tests were performed both in the presence and absence 
of oxygen. In the latter case, nitrogen was purged in the electrolyte for 15 min before the test. 
For the case of the enzymatic electrode, the affinity towards ACh was estimated in terms of the 
apparent Michaelis-Menten constant (Km 
app). This was calculated by using the electrochemical 
version of the Lineweaver-Burk equation of enzyme kinetics, as previously described (du Toit 
and Di Lorenzo 2014b):  
 
1
𝑖
=
1
𝑖𝑚𝑎𝑥
+
KM
app
𝑖𝑚𝑎𝑥 𝑐
 
 
Where i is the steady-state current observed after the addition of glucose; imax is the maximum 
current under the saturated concentration of glucose; c is the ACh concentration. 
2.3 Fuel cell fabrication and operation  
The single-chamber membrane-less hybrid EFC used in this work was fabricated in PDMS from 
a 3D printed mould, as previously described (du Toit et al. 2016). The device consisted of a 
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single chamber of 6 mm x 1 mm x 17 mm, hosting a AChE/hPG/Pt wire (the anode) and a Pt 
wire (as a combined counter/reference electrode), placed parallel to each other following the 
direction of flow. Each electrode was 10 mm long, with a total surface area exposed to the 
channel of 0.16 cm2. 
The inlet and outlet streams of the device were connected to a programmable multichannel 
peristaltic pump (Gilson, Miniplus 3), equipped with 2-stopped pump tubing. The device was 
continuously fed with an aerated PBS solution containing ACh (range: 2- 2400 g mL-1) at a rate 
of 0.4 ml min-1. During the operation, the electrodes were connected to an external circuit with 
an external fixed resistance (Rext) of 80 kΩ and to a PicoLog ADC-24 multichannel data logger 
to monitor the cell voltage (V). The current output (I) was calculated using Ohm’s law (I=V/ 
Rext) and the power was calculated as P= VI. Figure 1 shows the principle of operation of the 
AChE fuel cell. 
Polarisation tests were performed by Linear Sweep Voltammetry (LSV) using a scan rate of 1.0 
mV s-1, from the open circuit potential (OCP) to lower voltage regions.  
 
Figure 1. Design and working principle of the AChE fuel cell. The fuel cell consists of a membrane-less single 
channel that operates in flow-though mode. The cell hosts an anode (Pt wire coated with a film of highly porous 
gold, hPG) and a cathode, (Pt wire) connected to a external circuit with a fixed external load (Rext). AChE is 
immobilised onto the anode surface and catalyses the first step of oxidation of ACh, while hPG catalyses the 
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second. The electrons generated flow through the external circuit, thus producing a current output that is 
correlated to the amount of ACh oxidized. The reaction is completed at the cathode where the electrons combine 
with the protons and the oxygen to generate water. 
 
3. RESULTS AND DISCUSSION 
3.1 Electrochemical characterization of the AChE/hPG/Pt electrode 
The first part of this study concerned the development of an effective bioelectrode for ACh 
detection. To maximize the enzyme loading and facilitate direct electron transfer, highly porous 
gold structures were selected as the electrode material. Nanostructured electrode materials, such 
as hPG, have recently aroused tremendous interest, due to their large specific surface area 
leading to enhanced electron-transfer kinetics and their great biocompatibility (Kang and Lee 
2016). The immobilization of AChE onto hPG was achieved by electrochemical adsorption, 
through the rapid, efficient and low-cost methodology previously established by our group (du 
Toit and Di Lorenzo 2014b). At the physiological pH of 7.4 used in this study AChE has a 
negative charge (isoelectric point between 5.6 and 6.0). A potential of 0.6 V (vs SCE) was 
therefore chosen for its electrostatic immobilization to allow the building-up of a net positive 
charge onto the hPG electrode surface that would attract the oppositely charged enzyme. The 
electrochemical performance of the resulting AChE/hPG/Pt electrode was tested by SWV and 
CV in a conventional three-electrode set up, with SCE as the reference electrode and platinum 
wire as the auxiliary electrode (Figure 2). The electrochemical response of AChE/hPG/Pt was 
investigated in the absence (a) and presence (b) of 17 mM of acetylcholine, and compared with 
the case of the non-enzymatic hPG/Pt electrode (c). Initially the electrodes were tested in PBS 
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buffer. As shown in Figure 2A and 2C, the AChE/hPG/Pt electrode responded to the addition of 
ACh in solution with an up-shift in the SWV and CV curves in correspondence to 0.3 V. 
AChE hydrolyses ACh to choline and acetic acid, according to the following reaction (Step 1): 
ACh + H2O
AChE
→   CH3COOH + Ch 
Usually, the detection of ACh is achieved by the combined use of the enzyme AChE with 
choline oxidase, ChO, to allow the oxidation of Ch into H2O2, which is then electrochemically 
monitored (Kanik et al. 2013; Mitchell 2004). In the specific case of this study, the functional 
group(s) of Ch are instead directly electro-oxidised by hPG to generate oxidized intermediate(s), 
according to the following suggested reaction (Step 2):  
Ch + O2
hPG
→  oxidised intermediate(s) + H+ + e− 
The peak observed in both the SWV and CV curves is therefore related to Ch oxidation at the 
working electrode and is a consequence of AChE activity. The electro-oxidation of choline on 
nanostructured electrode structures has been already reported for the case of a nickel oxide 
nanostructured electrode (Sattarahmady et al. 2014). In particular, it was suggested that the 
process involves the oxidation of functional group(s) of Ch in either a single or multiple step. A 
similar process was suggested for thiocholine by Chauhan et al. with an iron 
nanoparticles/multiwalled carbon nanotubes modified gold electrode (Chauhan and Pundir 
2011). 
The hPG/Pt electrode also showed good reactivity towards ACh, with an oxidation peak at 0.27 
V (vs. SCE) (Figure 2A), which might be related to the oxidation of phosphate (du Toit and Di 
Lorenzo 2014a). To investigate this further, and study the interference of phosphate in the 
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electrochemical measurements, these tests were repeated in glycine buffer (Figure 2B and 2C). 
In the case of the AChE/hPG/Pt electrode, the oxidation peak at 0.30 V was confirmed. The 
response to ACh was, however, approximately two times higher than in buffer, with a ΔI≈ 0.04 
mA. Moreover, the intensity of the peak produced by hPG/Pt in glycine, was of only 0.01 mA. 
This value is 20% lower than the case of PBS, thus confirming the interference of phosphate. 
The two peaks observed in the SWV curves, probably related to oxidation reactions occurring 
onto the hPG surface, might have been masked in the case of PBS by the much larger peak 
related to phosphate oxidation. 
 
 
Figure 2 Electrochemical Square Wave Voltammetry (SWV) and Cyclic Voltammetry (CV) responses to ACh 
of the enzymatic and non-enzymatic hPG/Pt electrodes in PBS buffer (A, C) and glycine buffer (B, D). a) 
AChE/hPG/Pt electrode in the presence of 17 mM of ACh; b) AChE/hPG/Pt electrode in the absence of ACh; c) 
control, hPG/Pt electrode in buffer. The scan rate was of 50 mV s-1. 
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The response of both the enzymatic and non-enzymatic electrode to increasing ACh 
concentrations was subsequently tested by SWV and CA (at 0.3 V vs SCE). The results are 
reported in Figure 3. Both electrodes showed a very good response to ACh, and generated an 
output current signal proportional to its concentration. Considering its high reactivity, the 
response of hPG/Pt to ACh was not surprising (du Toit and Di Lorenzo 2014a). Although the 
electrocatalytic oxidation of ACh on nanostructured electrodes has already been shown 
(Sattarahmady et al. 2013), this is the first time that it is proven also for the case of porous gold. 
The type of buffer used had an influence on the response. Generally, in glycine the current 
generated by AChE/hPG/Pt was higher than hPG/Pt (Figure 3B and 3E), since there was no 
interference with phosphate in the reading. On the other hand, hPG/Pt generated a higher (Figure 
3C) or very similar (Figure 3F) current than the enzymatic electrode in PBS.  
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Figure 3 Chronoamperometry and SWV response of both the AChE/hPG/Pt and hPG/Pt electrodes for different 
concentrations of ACh, in either glycine or PBS buffer at pH 7.4 and in the presence of oxygen. refers to 
AChE/hPG/Pt;  refers to hPG/Pt. Chronoamperometry at 0.3 V: A) an example of chronoamperometry readings in 
glycine; B) current change versus ACh concentration in the case of glycine buffer; C) current change versus ACh 
concentration at 0.3 V in the case of phosphate buffer. Square Wave Voltammetry: D) an example of SWV readings 
in glycine, AChE/hPG/Pt electrode only; E) change in the current peak at 0.3 V versus ACh concentration in the 
case of glycine buffer; F) change in the current peak at 0.3 V versus ACh concentration in the case of PBS. Error 
bars refer to three replicates.  
 
Although the response to ACh and the shape of the calibration curves obtained with the two 
types of electrodes are very similar, the process occurring in each case is very different. In the 
case of AChE/hPG/Pt, choline is enzymatically generated (Step 1, Figure 1) and then oxidized 
by hPG (Step 2, Figure 1). In the other case, ACh is directly oxidized by hPG. To confirm this 
hypothesis, CV tests in the presence and absence of oxygen were performed (Figure 4). As 
shown, in the absence of oxygen AChE/hPG/Pt performs better, with a shift of approximately 
0.06 mA. This is because Step 1 is favoured by the absence of oxygen. On the other hand, when 
hPG/Pt was operated in the absence of oxygen no response to ACh was observed, with a flat CV.  
 
Figure 4- Cyclic voltammograms of both AChE/hPG/Pt (A) and hPG/Pt (B) electrodes in a PBS solution 
containing 0.6 mM of ACh in the presence (a) and absence (b) of oxygen. Scan rate: 50 mV s-1 
 15 
 
Considering the instability, cost and short lifetime of enzymes, a non-enzymatic sensor would 
be preferred. Nonetheless, enzymes are highly selective towards the target analyte. hPG is 
reactive to a number of compounds found in physiological fluids, such as sugars (du Toit and Di 
Lorenzo 2014a), and consequently a non-enzymatic hPG sensor would suffer from very poor 
selectivity. Practical applications of the hPG/Pt electrode would, therefore, necessarily imply the 
combined use of a functional membrane that filters out interfering compounds. This might prove 
difficult when these impurities have a molecular weight very close to ACh, such as glucose. We 
therefore focused on the enzymatic electrode only. 
Table 1 summarizes the performance of AChE/hPG/Pt in both glycine and PBS resulting from 
the CA tests and Figure S1 A and B in the supplementary data show the relative calibration 
curves obtained. As reported, in the case of glycine buffer, the sensitivity was almost two times 
higher than the case of PBS, with a value of 3.04 μA mM-1 cm-2, which corresponds to a slope of 
the calibration curve of approximately 0.5 μA mM-1. This sensitivity is comparable to the values 
observed for other AChE electrodes found in previous works: 0.49 μA mM-1 (Sen et al. 2004), 
and 0.42 μA mM-1 (Doretti et al. 2000) and it is much higher than the sensitivity of a Cu-
nanoparticle modified electrode with a sensitivity of only 0.23 μA mM-1 cm-2 (Heli et al. 2009). 
On the other hand, a much higher sensitivity has been recently reported with a non enzymatic 
metal oxide nanostructure (Sattarahmady et al. 2013). 
In the case of the non-enzymatic hPG/Pt electrode, the sensitivity is slightly higher, 4.6 μA mM-1 
cm-2, and also the linearity range is improved (Table 1S in the supplementary data). 
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From the reciprocal of the current - reciprocal of ACh concentration plot (Figure S3 and S4), it 
resulted a value of the apparent affinity, Km
app, equal to 0.3 mM, which is in agreement with 
previous findings on AChE immobilised onto porous gold structures (Shulga et al. 2007). This is 
a value much lower than previously reported (Doretti et al. 2000; Sen et al. 2004), thus 
demonstrating the high affinity of AChE/hPG/Pt towards ACh.  
 
Table 1. Analytical performance of the AChE/hPG/Pt electrode in both PBS and glycine buffer at pH 7.4. 
 PBS Glycine 
Linearity range 
(mM) 
0.24-1.9 0.12-1.4 
Sensitivity 
(μA mM-1 cm-2) 
2.01 ± 0.7 3.40 ± 1.3 
Kmapp 
(mM) 
0.30 ± 0.03 0.39 ± 0.2 
R2 (n=3) 0.98 0.98 
R2: correlation coefficient 
 
3.2 Self-Powered detection of Acetylcholine in continuous flow mode 
The AChE/hPG/Pt electrode was subsequently used as the anode of a flow-through 
membrane-less miniature fuel cell, with Pt as the cathode. The electrodes were connected 
through an external load and the system was continuously fed with PBS containing ACh at a 
flow rate of 0.35 ml min-1. No external mediators were added to the feeding solution. Power and 
polarisation curves, performed for increasing concentrations of ACh are shown in Figure 5. The 
polarisation curves exhibit a small activation region, a wide ohmic polarisation region and a 
short and steep mass transfer limitation region. This trend is in agreement with typical 
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polarisation curves obtained with biological fuel cells, where the ohmic losses play a dominant 
role (Logan et al. 2006). The polarisation curves up-shift with increasing concentrations of ACh 
and exhibit a corresponding open circuit potential within the range of 320 to 430 mV (Figure 
5B). It is expected that AChE/hPG/Pt is the limiting electrode in the fuel cell. Considering the 
effect that oxygen has on the performance of this electrode, as shown in Figure 4A, the very low 
current densities obtained could also be due to the saturating concentration of oxygen in the 
feeding solution used in this study (0.2 mM). It should be noted, however, that physiological 
fluids, such as plasma, present much lower oxygen concentrations and could therefore be 
associated with improved performance of the fuel cell (Falk et al. 2012). 
The power curves also show a good correlation between power output and ACh concentration 
(Figure 5A). The maximum power was of 4 nW at a voltage of 260 mV and for a current density 
of 9 μA cm-2 (ACh concentration: 10 mM). Since this is the first ACh/oxygen fuel cell reported, 
it is difficult to make a direct comparison on performance with other biological fuel cell devices 
reported in the literature, which are characterised by different device designs and catalyst used. 
Nonetheless, the performance of the ACh/O2 hybrid fuel cell in terms of power output, is very 
similar to other biological fuel cells reported (Falk et al. 2013; Falk et al. 2012). 
Although the power output is very low, the fuel cell showed an excellent response to varying 
acetylcholine concentrations, thus demonstrating its remarkable potential for use as a self-
powered ACh sensor. 
In Figure 5C a calibration curve is reported, obtained by connecting the two electrodes to an 
external resistor of 80 kΩ and varying the concentration of ACh in the feeding solution every 15 
min. The response time, calculated as the time to reach 95% of the final, was in the range of 2.8- 
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3.7 min, being lower for higher ACh concentrations. This is a much faster response than other 
AChE-based sensors previously reported (Doretti et al. 2000; Schuvailo et al.). 
The sensitivity of the sensor is of 0.1 μA mM-1 cm-2, with a lower detection limit of 10 μM. 
This detection limit is in the range of ACh concentrations in healthy individuals, but still too 
high for patients affected by AD, characterised by ACh values of 1 – 6 μM (Chauhan and Pundir 
2011). Still, these preliminary results are highly encouraging, and future research will 
necessarily have to focus on improving the fuel cell design and on maximising the electrode 
surface-area-to-volume ratio to enhance both the sensitivity and the limits of detection.  
 
 
Figure 5. Power curves (A) and polarization curves (B) obtained with PBS solutions of ACh with a 
concentration varying from 0.01 to 10 mM in PBS. Current density refers to the geometric surface area of the anode 
(0.16 cm2). (C) Current output generated by the flow-through AChE fuel cell at different ACh concentrations, for an 
external resistance of 80 kΩ. Error bars refer to at least two replicates. 
 
The fuel cell sensor showed high reproducibility, as demonstrated by the very small variation 
among several replicates reported in Figure 5C. Although the lifetime of the device was not 
tested, the hybrid fuel cell here proposed is expected to be stable for at least two days of 
continuous operation, according to our previous findings with a glucose/oxygen EFC having a 
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similar set-up (du Toit and Di Lorenzo 2015). In addition, compared to this previous study where 
the laccase electrode was supposed to be the major limiting factor for the system stability, the 
use of a Pt cathode in the hybrid fuel cell might contribute to a substantial enhancement in the 
system lifetime (Ivanov et al. 2010). Finally, preliminary studies have demonstrated that the 
immobilization of AChE onto porous structures help to increase its overall stability (Shulga et al. 
2007; Sotiropoulou et al. 2005). 
 
CONCLUDING REMARKS 
The development of rapid and low cost sensing devices for in situ monitoring of acetylcholine in 
plasma is key to enhance the therapy of the Alzheimer’s disease. In patients affected by this 
serious neuro-degeneration, the levels of the neurotransmitter acetylcholine can drop by up to 
90%. The consequence is a progressive and significant loss of cognitive and behavioural 
function. Effective in vivo monitoring of ACh can help with: timely diagnosis; monitoring 
treatment effectiveness; and developments of new medicines.  
Current methodologies for ACh detection are mainly based on microdialysis coupled with offline 
analysis, and are expensive, slow and not suitable for in situ monitoring.  
EFCs can provide an attractive alternative. In this study, we report the first acetylcholine/oxygen 
fuel cell and show an excellent response to ACh concentrations, in terms of both current and 
power output. No sample treatment is required and the response time is as fast as 3 min. As such, 
this research represents an important step towards self-powered low cost devices for the real time 
monitoring of ACh. 
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